Arrowhead Pharmaceuticals Receives Buy Rating from Chardan Capital - MarketBeat
| BHCUX Fund | USD 19.50 0.13 0.66% |
Slightly above 61% of Baron Health's investor base is looking to short. The analysis of overall sentiment of trading Baron Health Care mutual fund suggests that many investors are alarmed at this time. Baron Health's investing sentiment can be driven by a variety of factors including economic data, Baron Health's earnings reports, geopolitical events, and overall market trends.
Baron |
Arrowhead Pharmaceuticals Receives Buy Rating from Chardan Capital MarketBeat
Read at news.google.com
 |
Baron Health Fundamental Analysis
We analyze Baron Health's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Baron Health using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Baron Health based on its fundamental data. In general, a quantitative approach, as applied to this mutual fund, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Net Asset
Net Asset Comparative Analysis
Baron Health is currently under evaluation in net asset among similar funds. Net Asset is the current market value of a fund less its liabilities. In a nutshell, if the fund is liquidated or all of the assets is sold out, the net asset will be the amount that the shareholders would demand back from the fund.
Baron Health Care Potential Pair-trading
One of the popular trading techniques among algorithmic traders is to use market-neutral strategies where every trade hedges away some risk. Because there are two separate transactions required, even if one position performs unexpectedly, the other equity can make up some of the losses. Below are some of the equities that can be combined with Baron Health mutual fund to make a market-neutral strategy. Peer analysis of Baron Health could also be used in its relative valuation, which is a method of valuing Baron Health by comparing valuation metrics with similar companies.
Peers
Baron Health Related Equities
| BRIUX | Baron Real | 0.42 | ||||
| BRIFX | Baron Real | 0.42 | ||||
| BFIUX | Baron Fintech | 0.11 | ||||
| BWBTX | Baron Wealthbuilder | 0.05 | ||||
| BREUX | Baron Real | 0.65 | ||||
| BARUX | Baron Asset | 0.74 | ||||
| BEXUX | Baron Emerging | 0.79 | ||||
| BDAUX | Baron Durable | 1.09 | ||||
| BFGUX | Baron Focused | 1.18 | ||||
| BDFUX | Baron Discovery | 1.20 |
Other Information on Investing in Baron Mutual Fund
Baron Health financial ratios help investors to determine whether Baron Mutual Fund is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Baron with respect to the benefits of owning Baron Health security.
| Efficient Frontier Plot and analyze your portfolio and positions against risk-return landscape of the market. | |
| Global Markets Map Get a quick overview of global market snapshot using zoomable world map. Drill down to check world indexes | |
| Portfolio Rebalancing Analyze risk-adjusted returns against different time horizons to find asset-allocation targets |